US stock MEIP surges over 33% today, market capitalization rises to $41.24 million
According to ChainCatcher, market sources report that MEI Pharma (NASDAQ: MEIP) surged over 33% today, with its market capitalization rising to $41.2431 million.
Previous reports indicated that Titan Partners Group and crypto investment firm GSR are jointly leading a strategic transformation of U.S. pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. More than $100 million in funding commitments have already been made to the project. Litecoin founder Charlie Lee has agreed to join the MEI Pharma board of directors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Dinari integrates LayerZero to enable cross-chain trading of tokenized US stocks
Gold prices fall in early Asian trading as market doubts Fed rate cuts
JPMorgan: If Strategy stocks are removed from the index, they may face billions of dollars in capital outflows
AVAX One board approves stock repurchase plan of up to $40 million
Trending news
MoreCrypto prices
More
